TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li–Fraumeni family
Crossref DOI link: https://doi.org/10.1007/s10549-015-3424-1
Published Online: 2015-05-16
Published Print: 2015-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kappel, Sonja
Janschek, Elisabeth
Wolf, Brigitte
Rudas, Margaretha
Teleky, Bela
Jakesz, Raimund
Kandioler, Daniela
Text and Data Mining valid from 2015-05-16